David Slack

David Slack

Chief Executive Officer at Cend Therapeutics, Inc.

Net worth: 7 028 $ as of 2024-04-29

61 year
Health Technology
Consumer Services

Profile

David Slack is currently the President, Chief Executive Officer & Director at Cend Therapeutics, Inc. He is also the Chairman at Lisata Therapeutics Australia Pty Ltd.
Previously, he held positions such as Director-Technology Alliances & Licensing at Aventis Pharmaceuticals, Inc. and Rhone-Poulenc Rorer Pharmaceuticals, Inc. He was also the Vice President-Business Development at Ionis Pharmaceuticals, Inc. and the Chief Business Officer at Viracta Subsidiary, Inc. Additionally, he worked as a Principal at DS Lifescience Consulting.
Mr. Slack's education includes an undergraduate degree from California State University-Sacramento and an MBA from Monterey Institute of International Studies.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-04-28 2,642 ( 0.03% ) 7 028 $ 2024-04-29

David Slack active positions

CompaniesPositionStart
Chief Executive Officer 2020-07-07
Lisata Therapeutics Australia Pty Ltd. Chairman -
All active positions of David Slack

Former positions of David Slack

CompaniesPositionEnd
LISATA THERAPEUTICS, INC. President 2023-04-30
DS Lifescience Consulting Corporate Officer/Principal 2021-02-28
Corporate Officer/Principal 2020-06-30
IONIS PHARMACEUTICALS, INC. Corporate Officer/Principal 2003-12-31
Rhone-Poulenc Rorer Pharmaceuticals, Inc. Corporate Officer/Principal 1999-12-31
See the detail of David Slack's experience

Training of David Slack

California State University-Sacramento Undergraduate Degree
Monterey Institute of International Studies Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of David Slack's experience

Connections

67

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
IONIS PHARMACEUTICALS, INC.

Health Technology

LISATA THERAPEUTICS, INC.

Health Technology

Private companies6

Health Technology

Rhone-Poulenc Rorer Pharmaceuticals, Inc.

Health Technology

Health Technology

Lisata Therapeutics Australia Pty Ltd.

DS Lifescience Consulting

See company connections